View in EDS

Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).

Saved in:
Bibliographic Details
Title: Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
Authors: Boada M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Neve A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Das B; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wojtowicz J; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Huang Z; F. Hoffmann-La Roche Ltd, Shanghai, China., Bullain S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Watkin M; Roche Products Limited, Welwyn Garden City, UK., Lott D; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bittner T; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, Inc., South San Francisco, CA, USA., Delmar P; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Klein G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Hofmann C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kerchner GA; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Smith J; Roche Products Limited, Welwyn Garden City, UK., Baudler M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Fontoura P; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Doody RS; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, Inc., South San Francisco, CA, USA.
Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2025 Jan; Vol. 103 (2), pp. 528-541. Date of Electronic Publication: 2024 Dec 16.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39686620
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boada+M%22">Boada M</searchLink>; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Neve+A%22">Neve A</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Das+B%22">Das B</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wojtowicz+J%22">Wojtowicz J</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Huang+Z%22">Huang Z</searchLink>; F. Hoffmann-La Roche Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Bullain+S%22">Bullain S</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Watkin+M%22">Watkin M</searchLink>; Roche Products Limited, Welwyn Garden City, UK.<br /><searchLink fieldCode="AU" term="%22Lott+D%22">Lott D</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bittner+T%22">Bittner T</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Delmar+P%22">Delmar P</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Klein+G%22">Klein G</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hofmann+C%22">Hofmann C</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kerchner+GA%22">Kerchner GA</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Smith+J%22">Smith J</searchLink>; Roche Products Limited, Welwyn Garden City, UK.<br /><searchLink fieldCode="AU" term="%22Baudler+M%22">Baudler M</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fontoura+P%22">Fontoura P</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Doody+RS%22">Doody RS</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, Inc., South San Francisco, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229814863%22">Journal of Alzheimer's disease : JAD</searchLink> [J Alzheimers Dis] 2025 Jan; Vol. 103 (2), pp. 528-541. <i>Date of Electronic Publication: </i>2024 Dec 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9814863 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1875-8908 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213872877%22">13872877 </searchLink><i>NLM ISO Abbreviation: </i>J Alzheimers Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39686620
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13872877241303644
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 528
    Titles:
      – TitleFull: Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boada M
      – PersonEntity:
          Name:
            NameFull: Neve A
      – PersonEntity:
          Name:
            NameFull: Das B
      – PersonEntity:
          Name:
            NameFull: Wojtowicz J
      – PersonEntity:
          Name:
            NameFull: Huang Z
      – PersonEntity:
          Name:
            NameFull: Bullain S
      – PersonEntity:
          Name:
            NameFull: Watkin M
      – PersonEntity:
          Name:
            NameFull: Lott D
      – PersonEntity:
          Name:
            NameFull: Bittner T
      – PersonEntity:
          Name:
            NameFull: Delmar P
      – PersonEntity:
          Name:
            NameFull: Klein G
      – PersonEntity:
          Name:
            NameFull: Hofmann C
      – PersonEntity:
          Name:
            NameFull: Kerchner GA
      – PersonEntity:
          Name:
            NameFull: Smith J
      – PersonEntity:
          Name:
            NameFull: Baudler M
      – PersonEntity:
          Name:
            NameFull: Fontoura P
      – PersonEntity:
          Name:
            NameFull: Doody RS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1875-8908
          Numbering:
            – Type: volume
              Value: 103
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of Alzheimer's disease : JAD
              Type: main
ResultId 1